CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM NEW
Total 13F shares
3,175,066
Share change
+566,646
Total reported value
$1,147,068
Put/Call ratio
0%
Price per share
$0.36
Number of holders
27
Value change
+$176,088
Number of buys
7
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q3 2022

As of 30 Sep 2022, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,175,066 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, ROYCE & ASSOCIATES LP, Bank of New York Mellon Corp, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, and SIGNATUREFD, LLC. This page lists 27 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.